The Ras signaling pathway allows cells to translate external cues into diverse biological responses. Depending on context and the threshold reached, Ras signaling can promote growth, proliferation, differentiation, or cell survival. Failure to maintain precise control of Ras can have adverse physiological consequences. Indeed, excess Ras signaling disrupts developmental patterning and causes developmental disorders [1, 2] , and in mature tissues, it can lead to cancer [3] [4] [5] . We identify Rabex-5 as a new component of Ras signaling crucial for achieving proper pathway outputs in multiple contexts in vivo. We show that Drosophila Rabex-5 restricts Ras signaling to establish organism size, wing vein pattern, and eye versus antennal fate. Rabex-5 has both Rab5 guanine nucleotide exchange factor (GEF) activity that regulates endocytic trafficking [6] and ubiquitin ligase activity [7, 8] . Surprisingly, overexpression studies demonstrate that Rabex-5 ubiquitin ligase activity, not its Rab5 GEF activity, is required to restrict wing vein specification and to suppress the eye phenotypes of oncogenic Ras expression. Furthermore, genetic interaction experiments indicate that Rabex-5 acts at the step of Ras, and tissue culture studies show that Rabex-5 promotes Ras ubiquitination. Together, these findings reveal a new mechanism for attenuating Ras signaling in vivo and suggest an important role for Rabex-5-mediated Ras ubiquitination in pathway homeostasis.
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Results and Discussion

Rabex-5 Loss Causes Increased Size
We characterized the gene Rabex-5 (also called RabGEF1, annotated CG9139; see Figure S1 available online) in Drosophila. Rabex-5 was first identified as a Rab5 guanine nucleotide exchange factor (GEF) with a highly conserved VPS9 domain [6] . Studies of Rab5 and other VPS proteins indicate that they play a role in growth control [9, 10] . We used gal4/UAS expression [11] of an inverted repeat allele of Rabex-5, Rabex-5 IR [12] , to perform tissue-specific RNA interference (RNAi), and we generated deletion alleles Rabex-5 ex9 , Rabex-5 ex40 , and Rabex-5 ex42 ( Figure S1 ; Supplemental Experimental Procedures).
Deletion allele homozygotes, heterozygotes with one copy of Rabex-5 ex9 , Rabex-5 ex40 , or Rabex-5 ex42 over the large deletion Df(3L)BSC250, and flies undergoing strong, constitutive Rabex-5 RNAi died as giant larvae or giant pupae, often containing melanotic tumors (Figures 1A and 1B ; data not shown). Using RNAi conditions to reduce but not eliminate Rabex-5 resulted in viable adults whose length, weight, and wing size increased by over 10% (Figures 1C-1E ). Figure S1 ) compared to controls ( Figures 1F and 1H ). Removing one copy of Rabex-5 enhanced Rabex-5 RNAi in the wing ( Figure 1J ), and homozygous Rabex-5 ex42 mutant wing tissue also formed extra veins ( Figure S1 ). Thus, it is unlikely this phenotype resulted from RNAi off-target effects.
Loss of
Strong Rabex-5 RNAi in the early eye led to 10%-25% of eyes with severe phenotypes, including overgrown eyes, outgrowths, small or lost eyes, and extra antennae ( Figures  1M-1P ; Figure S1 ), that were not observed in controls ( Figure 1L ). Similar phenotypes were seen in eyes containing primarily Rabex-5 ex42 mutant tissue ( Figure S1 ).
Rabex-5 Mutant Larvae Exhibit Increased ERK Activity
These phenotypes are consistent with failure to regulate Ras. Increased Ras signaling causes melanotic tumors [13] , as seen upon loss of Rabex-5. Ras activity is required for wing vein specification and, in excess, causes ectopic veins [14, 15] , as seen upon Rabex-5 reduction. Ras is also important in the eye. Increased Ras signaling early in eye development induces hyperplastic growth [16] , and exceeding certain thresholds may promote antennal fates instead of eye fates [17] . Eye phenotypes from Rabex-5 loss are consistent with Ras activity near the threshold between driving hyperplasia and promoting an eye-to-antenna switch. To evaluate Ras signaling, we assessed dually phosphorylated ERK (dpERK), a downstream Ras effector. Western analysis showed 2.5-fold to 5-fold increased ERK activity in mutant larvae compared to controls when normalized for total ERK ( Figure 1Q ; Figure S1 ). Previous in vitro studies reported that Rabex-5 loss in mast cells in culture extended the duration of ERK activation when triggered by aggregation of Fc3R1 receptors or by stem cell factor [18, 19] , consistent with our in vivo findings.
Size, Eye, and Wing Phenotypes Are Ras Dependent Ras mutations dominantly suppressed the extra wing veins caused by constitutive and wing-specific Rabex-5 RNAi ( Figure 1K ; Figure S1 ), reduced the percentage of flies with severe eye phenotypes upon Rabex-5 RNAi ( Figure 1P ), and suppressed the increased body size, body length, and wing area of constitutive Rabex-5 RNAi ( Figure 1D ; Figure S1 ). Body weight of all flies and wing area in female flies were no longer statistically different from controls. Mutations in Egfr, sos, Raf, MEK, and ERK dominantly suppressed the extra PCV RNAi phenotype ( Figure S1 ). Mutation in ERK also dominantly suppressed homozygous Rabex-5 ex42 phenotypes ( Figure S1 ).
These data indicate that Rabex-5 restricts Ras signaling through ERK to achieve appropriate organism size, to specify *Correspondence: cathie.pfleger@mssm.edu wing vein pattern, and to establish eye versus antennal fate in Drosophila.
Loss of Rabex-5 Enhances Activated Ras and Egfr but Not Raf
If Rabex-5 restricts Ras signaling, mutations activating the pathway in an otherwise wild-type background may be somewhat inhibited by endogenous Rabex-5. Therefore, loss of Rabex-5 might exacerbate the consequence of expressing activated pathway components. Activated Egfr (Egfr A887T ), RasV12S35 (oncogenic Ras signaling primarily through ERK), and Raf (Raf gof ) [20] (details in Supplemental Experimental Procedures) expression in differentiating eye cells each caused rough eyes of reduced size (Egfr A887T , Figure 2A , Figure S2 ; RasV12S35, Figure 2B , Figure S2 ; Raf gof , data not shown). As these phenotypes worsened, we observed black tissue and lethality ( Figure S2 ). Loss of Rabex-5 significantly enhanced the number of eyes with black tissue and significantly increased lethality of Egfr A887T or RasV12S35 expression (Figures 2A-2C ; Figure S2 ). Rabex-5 RNAi in differentiating eye cells resulted in no obvious abnormalities ( Figure S2 ), so phenotypic enhancement was not likely due to additive effects of combining two visible phenotypes. Unlike its enhancement of Egfr A887T and RasV12S35 phenotypes, reducing Rabex-5 in differentiating eye cells did not enhance the phenotype of Raf gof expression ( Figure 2C ; data not shown).
Expressing RasV12S35 in the early eye results in eye overgrowth and other abnormalities; loss of Rabex-5 dramatically enhanced these phenotypes (Figures 2G and 2H ; Figure S2) , notably the overgrowth, extra antennae, and ectopic eye phenotypes in larval eye discs (Figures 2G and 2H ; Figure S2 ) compared to control discs ( Figures 2D-2F ).
The Ubiquitin Ligase Domain of Rabex-5 Restricts Wing Vein Formation Rabex-5 displays GEF activity for Rab5 [8] . Rab5 regulates endocytosis and can influence receptor trafficking, so Rabex-5 could inhibit Ras via Rab5. In addition, Rabex-5 has a ubiquitin ligase domain [9, 10] . We engineered Drosophila transgenic lines to express myc-tagged wild-type and mutant forms of Rabex-5. Rabex-5
DPYT was designed to inactivate Rab5 GEF activity, and Rabex-5 FY was designed to inactivate ubiquitin ligase activity within full-length protein (Supplemental Experimental Procedures). Both Rabex-5
WT and Rabex-5 DPYT expressed in the posterior wing resulted in loss of crossveins and loss of the distal part of longitudinal vein L5 ( Figures 3B, 3C , and 3E; Figure S3 ) compared to a control wing ( Figure 3A) . In contrast, Rabex-5 FY did not alter wing vein pattern ( Figures 3D and 3E ). These results indicate that the ubiquitin ligase domain restricts wing vein formation. Clones of Rabex-5 DPYT in wing discs showed loss of dpERK staining ( Figures 3F-3H . dpERK (top) and total ERK (bottom) staining showed 3.9-fold 6 0.23 (standard deviation) increased ERK activation in mutant larvae compared to controls. Additional controls are shown in Figure S1 .
Rabex-5 Ubiquitin Ligase Domain Blocks Activated Ras in the Eye
If Rabex-5 inhibits Ras, it could antagonize oncogenic Ras. To assay suppression, we expressed RasV12S35 in differentiating eye cells using conditions resulting in black tissue in 30% of eyes. Rabex-5
WT and Rabex-5 DPYT each reduced roughness, eye size, and black tissue phenotypes of RasV12S35-expressing eyes ( Figures 4A, 4B , and 4D; Figure S4 ). Change in roughness was subtle; eyes were scored double blind by other laboratory members to confirm suppression in an unbiased manner. By quantitation, Rabex-5 WT and Rabex-5 DPYT statistically significantly suppressed the reduced eye size and black tissue phenotypes compared to RasV12S35 eyes ( Figure 4D ; Figure S4 ). Rescued eyes were statistically no different in size from controls. Rabex-5 FY did not suppress RasV12S35 phenotypes (Figures 4C and 4D ; Figure S4 ). Consistent with Figure 2C , Rabex-5
WT did not suppress appearance of black tissue in Raf gof eyes ( Figure S4 ). Enhancement of RasV12S35 by Rabex-5 loss (Figure 2 ) and its suppression by the Rabex-5 ubiquitin ligase domain (Figure 4 ), together with failure of Rabex-5 to suppress the Raf gof phenotype and its loss to enhance Raf gof ( Figure 2 ; Figure 4 ; data not shown), indicate that Rabex-5 restricts Ras signaling through its ubiquitin ligase domain most likely at the step of Ras.
Rabex-5 Promotes Ras Ubiquitination
The importance of a functional ubiquitin ligase domain for Ras inhibition suggests that ubiquitination of one or more substrates mediates effects on Ras signaling. Previously, we and others showed that Ras ubiquitination reduces Ras signaling to ERK [21, 22] . In S2 cells, Rabex-5 promoted Ras ubiquitination via its ligase domain ( Figure 4E ; Figure S4 ), but, showing specificity for Ras, Rabex-5 did not promote Rab5 ubiquitination ( Figure S4 ). F25 Y26 mutation impairs ubiquitin binding [7] ; therefore, Rabex-5 could bind ubiquitinated Ras to block downstream signaling or Rabex-5 may affect Ras by targeting other substrates. However, the simplest model is that Rabex-5 constrains Ras signaling by direct Ras ubiquitination. In fact, mammalian Rabex-5 promotes Ras ubiquitination in a purified system ( [23] , this issue of Current Biology).
Conclusions
Our findings represent the first evidence that Rabex-5 attenuates Ras signaling in vivo. We show that inhibition occurs at the step of Ras possibly by direct Ras ubiquitination, and such inhibition plays a critical role in control of size and tissue fate in Drosophila. Mammalian Rabex-5 promotes ubiquitination of HRas and NRas [23] , suggesting that Rabex-5 restriction of Ras is highly conserved. Interestingly, we did not see supernumary R7 cells upon Rabex-5 loss (data not shown), indicating that Rabex-5 antagonizes Ras in some, but not all, developmental contexts. Germline mutations increasing Ras signaling occur in ''Rasopathies'' [1, 2] , which are associated with patterning defects, making Rabex-5 an attractive candidate to evaluate in developmental disorders. Indeed, Rabex-5 wing vein phenotypes resemble those seen in a Drosophila model of Noonan Syndrome [24] . Somatic mutations causing higher Ras activity are common in cancer [3] [4] [5] . Rabex-5 overgrowth phenotypes resemble those of mutation in many Drosophila tumor suppressors [25, 26] . Thus, our study suggests that Rabex-5 ubiquitin ligase activity could serve as a novel means of tumor suppression.
Experimental Procedures
Student's unpaired t tests compared length, weight, wing area ( Figure 1D ), and eye size ( Figure 4D ). Chi-square or Fisher's exact tests compared PCV, LV, or eye phenotypes (Figures 1K and 1P ; Figures 2C and 2H; Figure 3E ; Figure 4D ). S2 cells cultured at 25 C were transfected with pIE [1] [2] [3] [4] -Flag-6His-Ras, Actin-Gal4, UAS-HA-Ubiquitin, and UAS-myc-Rabex-5 using Cellfectin (Invitrogen). Ubiquitin conjugates were isolated from cell lysates as described [21] . Flies were raised on standard media at 25 C unless otherwise stated. Larvae were dissected, stained, and imaged as before [21] . Extracts were prepared from individual larvae, and western blots were visualized with the Li-Cor Odyssey as before [21] . For genotypes and additional details, see the Supplemental Experimental Procedures. Figure S3 .
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